Russian authorities have begun restricting access to Telegram, one of the country’s most popular social media apps, as the government continues to push everyday Russians toward its own tightly ...

Russia’s communications regulator is continuing to crack down on apps like Telegram and WhatsApp while rolling out a state-backed alternative, Max. Russia’s communications regulator is continuing to ...

Russia's communications regulator, Roskomnadzor, began restricting the operation of Telegram on Feb. 10, targeting one of the country's most widely used messaging platforms, the regulator said. The ...

After introducing little bits and pieces last year, Telegram’s new update on Android is going all-in on Liquid Glass with new design elements throughout the UI in what is a pretty major redesign.

Can computer programs have faith? Can they conspire against the humans that created them? Or feel melancholy? On a social media platform built just for artificial intelligence bots, some of them are ...

It’s the kind of back-and-forth found on every social network: One user posts about their identity crisis and hundreds of others chime in with messages of support, consolation and profanity. In the ...

Keep scrolling to read our original story on the name change. Clawdbot has been on quite the ride. The free, open-source AI assistant has gone viral on platforms like X, where early adopters, AI ...

Cross Bot will analyze your games in Crossplay, a new two-player word game from The Times. By Asmaa Elkeurti Tom Giratikanon and Eve Washington New York Times Games has launched Crossplay, a new ...

The Russian billionaire who founded messaging app Telegram is fighting infertility, but he isn’t using his wallet — he is using his own sperm. Pavel Durov, 41, has offered to cover the full cost of in ...

The Bot Company, a startup working on robots that can do chores for people, is set to raise $250 million in a funding round that will value the company at more than $4 billion, according to people ...

The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...